or
forgot password
  • cancer clinical trials in new haven, CT

  • Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
    Yale University
    New Haven, Connecticut 06520
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Study of Oral AEE788 in Adults With Advanced Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cancer
    AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
    Yale University New Haven Medical Center
    New Haven, Connecticut 06510
    Endometrial Cancer
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Urologic Center
    New Haven, Connecticut 06511
    Prostate Cancer, Osteoporosis, Fractures
    Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Breast Cancer
    Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Multiple Myeloma
    Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Lymphoma, T-Cell, Cutaneous
    Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery
    Yale University
    New Haven, Connecticut 06520
    Recurrent Melanoma, Recurrent Renal Cell Cancer, Stage III Melanoma, Stage IV Melanoma, Stage IV Renal Cell Cancer
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin's Lymphoma
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    Yale University Medical Center
    New Haven, Connecticut 06520
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Brain and Central Nervous System Tumors
    Study of BMS-663513 in Patients With Advanced Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Tumors
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    Yale University Multiple Sclerosis Center
    New Haven, Connecticut 06510
    Multiple Sclerosis
    Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer
    Yale Cancer Genetic Counseling, Yale Cancer Center, Yale University School of Medicine
    New Haven, Connecticut 06510
    Menopause
    Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Peripheral T-cell Lymphoma
    Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Graft Versus Host Disease
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yale University
    New Haven, Connecticut 06520
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Fallopian Tube Cancer, Peritoneal Neoplasms, Ovarian Cancer
    Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
    Advanced Diagnostic Pain Treatment Center
    New Haven, Connecticut 06511
    Pain, Chronic Pain, Breakthrough Pain
    Evaluating Patients With Varying Degrees of Renal Function
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Renal Impairment
    Evaluating Patients With Impaired Hepatic Function
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Impaired Hepatic Function
    A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Metastatic Melanoma
    A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
    Yale University
    New Haven, Connecticut 06520
    Unresectable Stage III or Stage IV Melanoma
    Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Solid Tumor, Lymphoma
    Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Lung Cancer
    Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
    Yale University
    New Haven, Connecticut 06520
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Venous Thrombosis, Pulmonary Embolism
    Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
    Yale University, Comprehensive Cancer Center
    New Haven, Connecticut 06520
    Advanced Cancers
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Leukemia
    AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
    Yale University
    New Haven, Connecticut 06520
    Pancreatic Cancer
    Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Cutaneous T-cell Lymphoma (CTCL),
    Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
    Yale University, School of Medicine
    New Haven, Connecticut 06520
    Anaplastic Thyroid Cancer
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    Yale University Multiple Sclerosis Center
    New Haven, Connecticut 06510
    Multiple Sclerosis, Relapsing-Remitting
    Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Cutaneous T-cell Lymphoma
    A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Prostate Cancer
    Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure
    Vascular and Interventional Radiology
    New Haven, Connecticut 208042
    Pneumothorax
    Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Solid Tumors
    Phase II, 2nd Line Melanoma - RAND Monotherapy
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Melanoma
    Repair of Infected or Contaminated Hernias
    Hospital of St Rafael
    New Haven, Connecticut
    Hernia
    A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
    Yale University School of Medicine YaleCancerCtr-ClinTrialsOffice
    New Haven, Connecticut 06520
    Breast Cancer,, Advanced Solid Tumors,, Cowden Syndrome
    Study of Ipilimumab to Treat Melanoma in Patients With Brain Metastases
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Melanoma
    Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance
    Yale Center for Clinical Investigation (YCCI)
    New Haven, Connecticut 06511
    Pediatric Obesity, Insulin Resistance, Hyperinsulinemia
    ChemoFx® PRO - A Post-Market Data Collection Study
    Yale University
    New Haven, Connecticut 06520
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Ultrasound Elastography of Breast Lesions
    Yale Medical Center, Department of Diagnostic Radiology
    New Haven, Connecticut 06510
    Breast Neoplasms
    Pregnancy in Polycystic Ovary Syndrome II
    Yale University
    New Haven, Connecticut 06520
    Pregnancy, Polycystic Ovary Syndrome
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Ovarian Cancer
    A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Non Small Cell Lung Cancer
    Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
    Yale New Haven Hospital
    New Haven, Connecticut 06520
    Rheumatoid Arthritis
    Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Non-Small Cell Lung Cancer (NSCLC)
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Transfusional Hemosiderosis
    Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma
    Yale Comprehensive Cancer Center
    New Haven, Connecticut 06520-8028
    Peripheral T-Cell Lymphoma
    Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Renal Cell Carcinoma, Non-hodgkin's Lymphoma
    Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease
    Yale University
    New Haven, Connecticut 06520
    Gaucher Disease, Type 1
    Inflammatory Cytokines Associated With Perinatal Brain Injury
    Yale University
    New Haven, Connecticut 06520
    Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Cerebral Palsy
    Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Colorectal Cancer
    In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors
    Yale University
    New Haven, Connecticut 06520
    Pancreatic Cysts
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    Yale Multiple Sclerosis Center
    New Haven, Connecticut 06510
    Multiple Sclerosis
    Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery
    Yale Dermatologic Surgery
    New Haven, Connecticut 06510
    Basal Cell Carcinoma, Squamous Cell Carcinoma
    Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes
    Yale Cancer Center

    Trial Locations
    Yale Cancer Center
    Yale-New Haven Hospital
    Smoking Cessation
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Yale University
    New Haven, Connecticut 06520
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma
    Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.
    Yale University School of Medicine dept of Onc
    New Haven, Connecticut 06520
    Locally Advanced or Metastatic BRAF Mutant Melanoma
    Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease
    Yale Alzheimer's Disease Research Unit
    New Haven, Connecticut 06510
    Alzheimer's Disease
    Text Messaging to Improve Adherence to Oral Chemotherapy Agents
    Yale University
    New Haven, Connecticut 06520
    Cancer